Cargando…
Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment
A 76-year-old Japanese man with nephrotic syndrome was admitted to our department for treatment. After his admission, he was administered prednisolone (PSL) at 40 mg/day, and a percutaneous renal biopsy was performed. However, on the first day of admission, his urinary protein decreased from 5.05 g/...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665908/ https://www.ncbi.nlm.nih.gov/pubmed/36407214 http://dx.doi.org/10.7759/cureus.30346 |
_version_ | 1784831388333113344 |
---|---|
author | Torigoe, Kenta Ikemi, Yuta Yoshida, Yuki Sakamoto, Ryosuke Yamashita, Ayuko Abe, Shinichi Muta, Kumiko Arai, Hideyuki Mukae, Hiroshi Nishino, Tomoya |
author_facet | Torigoe, Kenta Ikemi, Yuta Yoshida, Yuki Sakamoto, Ryosuke Yamashita, Ayuko Abe, Shinichi Muta, Kumiko Arai, Hideyuki Mukae, Hiroshi Nishino, Tomoya |
author_sort | Torigoe, Kenta |
collection | PubMed |
description | A 76-year-old Japanese man with nephrotic syndrome was admitted to our department for treatment. After his admission, he was administered prednisolone (PSL) at 40 mg/day, and a percutaneous renal biopsy was performed. However, on the first day of admission, his urinary protein decreased from 5.05 g/gCr to 1.85 g/gCr. On the fourth day of admission, his urinary protein further decreased to 0.38 g/gCr and the patient developed acute kidney injury (AKI). Renin-angiotensin system (RAS) inhibitors were suspected to be the cause of AKI; therefore, they were discontinued. After the renal function improved, the urinary protein worsened again to 5.49 g/gCr. Renal pathology suggested minimal change disease (MCD); therefore, PSL was continued. The patient’s urinary protein subsequently improved and he had no renal function impairment. Minimal change disease can be complicated by AKI through intravascular volume depletion caused by high urinary protein and hypoalbuminemia. However, when MCD is complicated by RAS inhibitor-associated AKI, the urinary protein may notably decrease, and the patient may present with an atypical course of MCD-associated AKI. |
format | Online Article Text |
id | pubmed-9665908 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-96659082022-11-17 Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment Torigoe, Kenta Ikemi, Yuta Yoshida, Yuki Sakamoto, Ryosuke Yamashita, Ayuko Abe, Shinichi Muta, Kumiko Arai, Hideyuki Mukae, Hiroshi Nishino, Tomoya Cureus Nephrology A 76-year-old Japanese man with nephrotic syndrome was admitted to our department for treatment. After his admission, he was administered prednisolone (PSL) at 40 mg/day, and a percutaneous renal biopsy was performed. However, on the first day of admission, his urinary protein decreased from 5.05 g/gCr to 1.85 g/gCr. On the fourth day of admission, his urinary protein further decreased to 0.38 g/gCr and the patient developed acute kidney injury (AKI). Renin-angiotensin system (RAS) inhibitors were suspected to be the cause of AKI; therefore, they were discontinued. After the renal function improved, the urinary protein worsened again to 5.49 g/gCr. Renal pathology suggested minimal change disease (MCD); therefore, PSL was continued. The patient’s urinary protein subsequently improved and he had no renal function impairment. Minimal change disease can be complicated by AKI through intravascular volume depletion caused by high urinary protein and hypoalbuminemia. However, when MCD is complicated by RAS inhibitor-associated AKI, the urinary protein may notably decrease, and the patient may present with an atypical course of MCD-associated AKI. Cureus 2022-10-16 /pmc/articles/PMC9665908/ /pubmed/36407214 http://dx.doi.org/10.7759/cureus.30346 Text en Copyright © 2022, Torigoe et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Nephrology Torigoe, Kenta Ikemi, Yuta Yoshida, Yuki Sakamoto, Ryosuke Yamashita, Ayuko Abe, Shinichi Muta, Kumiko Arai, Hideyuki Mukae, Hiroshi Nishino, Tomoya Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment |
title | Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment |
title_full | Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment |
title_fullStr | Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment |
title_full_unstemmed | Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment |
title_short | Acute Kidney Injury Caused by Renin-Angiotensin System Inhibitors During Minimal Change Disease Treatment |
title_sort | acute kidney injury caused by renin-angiotensin system inhibitors during minimal change disease treatment |
topic | Nephrology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665908/ https://www.ncbi.nlm.nih.gov/pubmed/36407214 http://dx.doi.org/10.7759/cureus.30346 |
work_keys_str_mv | AT torigoekenta acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment AT ikemiyuta acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment AT yoshidayuki acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment AT sakamotoryosuke acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment AT yamashitaayuko acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment AT abeshinichi acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment AT mutakumiko acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment AT araihideyuki acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment AT mukaehiroshi acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment AT nishinotomoya acutekidneyinjurycausedbyreninangiotensinsysteminhibitorsduringminimalchangediseasetreatment |